

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.30765744 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.30765744 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.30765744 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.30765744 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.30765744 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.30765744 |
| 7 | response to peptidoglycan (GO:0032494) | 4.54400288 |
| 8 | apoptotic cell clearance (GO:0043277) | 4.05385725 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.92772000 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.92113438 |
| 11 | protein carboxylation (GO:0018214) | 3.92113438 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.83779393 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.78139939 |
| 14 | respiratory burst (GO:0045730) | 3.75820958 |
| 15 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.75757688 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.66752394 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.66752394 |
| 18 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.65155073 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.61458813 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59656177 |
| 21 | germinal center formation (GO:0002467) | 3.59639774 |
| 22 | low-density lipoprotein particle clearance (GO:0034383) | 3.59260984 |
| 23 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.56328458 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55305909 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.50613473 |
| 26 | response to host immune response (GO:0052572) | 3.50613473 |
| 27 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.49051340 |
| 28 | cellular extravasation (GO:0045123) | 3.46159659 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45650230 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.43571095 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.43378296 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.42232857 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.39740713 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.38387871 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.37019329 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36034149 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36034149 |
| 38 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.34780638 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.24513997 |
| 40 | reactive oxygen species biosynthetic process (GO:1903409) | 3.24330856 |
| 41 | detection of bacterium (GO:0016045) | 3.24189586 |
| 42 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23537293 |
| 43 | detection of molecule of bacterial origin (GO:0032490) | 3.19364389 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18966347 |
| 45 | response to host (GO:0075136) | 3.18966347 |
| 46 | response to host defenses (GO:0052200) | 3.18966347 |
| 47 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.08527351 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.07724318 |
| 49 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.04499774 |
| 50 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.99802809 |
| 51 | detection of biotic stimulus (GO:0009595) | 2.99584551 |
| 52 | regulation of podosome assembly (GO:0071801) | 2.95989864 |
| 53 | positive regulation of lipid storage (GO:0010884) | 2.93240330 |
| 54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93170200 |
| 55 | response to protozoan (GO:0001562) | 2.92732537 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 2.92357341 |
| 57 | granulocyte activation (GO:0036230) | 2.91467855 |
| 58 | defense response to protozoan (GO:0042832) | 2.91014563 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 2.90944965 |
| 60 | microglial cell activation (GO:0001774) | 2.90791763 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90712812 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 2.89916949 |
| 63 | superoxide anion generation (GO:0042554) | 2.89870651 |
| 64 | negative regulation of lipid storage (GO:0010888) | 2.86403892 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84693749 |
| 66 | urea cycle (GO:0000050) | 2.84497604 |
| 67 | urea metabolic process (GO:0019627) | 2.84497604 |
| 68 | macrophage activation (GO:0042116) | 2.84214406 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.83601980 |
| 70 | type I interferon signaling pathway (GO:0060337) | 2.83573926 |
| 71 | cellular response to type I interferon (GO:0071357) | 2.83573926 |
| 72 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.83329069 |
| 73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82863413 |
| 74 | positive regulation of mast cell degranulation (GO:0043306) | 2.82863413 |
| 75 | positive regulation of p38MAPK cascade (GO:1900745) | 2.81871612 |
| 76 | regulation of chemokine biosynthetic process (GO:0045073) | 2.81520648 |
| 77 | glycosphingolipid catabolic process (GO:0046479) | 2.80417291 |
| 78 | regulation of vitamin metabolic process (GO:0030656) | 2.80090803 |
| 79 | complement activation, alternative pathway (GO:0006957) | 2.79532557 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 2.79019679 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.78707620 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.78188676 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75830933 |
| 84 | protein localization to endosome (GO:0036010) | 2.75325055 |
| 85 | neutrophil activation (GO:0042119) | 2.74689610 |
| 86 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.73197770 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 2.72768072 |
| 88 | positive regulation of hemostasis (GO:1900048) | 2.72768072 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72719541 |
| 90 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72564885 |
| 91 | leukocyte aggregation (GO:0070486) | 2.72277224 |
| 92 | oligosaccharide catabolic process (GO:0009313) | 2.72109370 |
| 93 | positive regulation of coagulation (GO:0050820) | 2.71953376 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69071812 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67218841 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65464415 |
| 97 | T-helper 1 type immune response (GO:0042088) | 2.64573303 |
| 98 | phospholipid efflux (GO:0033700) | 2.63443000 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.63349698 |
| 100 | response to thyroid hormone (GO:0097066) | 2.62687033 |
| 101 | positive regulation of cholesterol efflux (GO:0010875) | 2.62265380 |
| 102 | positive regulation of interferon-beta production (GO:0032728) | 2.61961864 |
| 103 | positive regulation of sterol transport (GO:0032373) | 2.61918439 |
| 104 | positive regulation of cholesterol transport (GO:0032376) | 2.61918439 |
| 105 | amino sugar catabolic process (GO:0046348) | 2.61172401 |
| 106 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60861970 |
| 107 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.59985793 |
| 108 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.59841475 |
| 109 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.59263659 |
| 110 | cellular response to lipopolysaccharide (GO:0071222) | 2.58801172 |
| 111 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58669775 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58498755 |
| 113 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58407056 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.57103583 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 2.57082189 |
| 116 | response to laminar fluid shear stress (GO:0034616) | 2.56564507 |
| 117 | cellular response to molecule of bacterial origin (GO:0071219) | 2.56229079 |
| 118 | response to fungus (GO:0009620) | 2.55114868 |
| 119 | I-kappaB phosphorylation (GO:0007252) | 2.54741765 |
| 120 | positive regulation of type 2 immune response (GO:0002830) | 2.54166428 |
| 121 | regulation of mononuclear cell migration (GO:0071675) | 2.54146985 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.52743450 |
| 123 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.52629240 |
| 124 | negative regulation of interleukin-6 production (GO:0032715) | 2.52174198 |
| 125 | positive regulation of interleukin-6 production (GO:0032755) | 2.51400957 |
| 126 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.51311591 |
| 127 | detection of other organism (GO:0098543) | 2.51257348 |
| 128 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.51066732 |
| 129 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.51066732 |
| 130 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.50453704 |
| 131 | neutrophil chemotaxis (GO:0030593) | 2.49967966 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.48708870 |
| 133 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.47783816 |
| 134 | monocyte chemotaxis (GO:0002548) | 2.47718924 |
| 135 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47524934 |
| 136 | regulation of mast cell activation (GO:0033003) | 2.44522115 |
| 137 | positive regulation of lipid catabolic process (GO:0050996) | 2.44290933 |
| 138 | lipoxygenase pathway (GO:0019372) | 2.43017535 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.42990598 |
| 140 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42879508 |
| 141 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.42606300 |
| 142 | response to type I interferon (GO:0034340) | 2.41703838 |
| 143 | positive regulation of leukocyte degranulation (GO:0043302) | 2.41594636 |
| 144 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.41445130 |
| 145 | B cell mediated immunity (GO:0019724) | 2.41109774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32787978 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.26297334 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.24290598 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03676035 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39522706 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23071120 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20821250 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.05979294 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03541781 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96878314 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96050739 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88267690 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79164548 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78979463 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72546213 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68970933 |
| 17 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67345377 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64923566 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.63891544 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.45591798 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42778379 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28186723 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26704317 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23050943 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20682400 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18151843 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.04580117 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04541230 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98016745 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96761362 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85792445 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85728916 |
| 33 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83758112 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.76220621 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73433887 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68757662 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67118633 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64544414 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64162613 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60880950 |
| 41 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.60329271 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59318800 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50792623 |
| 44 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49387219 |
| 45 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47921241 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46961341 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44888612 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44795995 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43408820 |
| 50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42434142 |
| 51 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42085370 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41864874 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41097042 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38418452 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38286758 |
| 56 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.36538048 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36248831 |
| 58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35742580 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31834308 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31724191 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28872259 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28794592 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27743819 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26927238 |
| 65 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25446190 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24683649 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22263750 |
| 68 | * MYB_26560356_Chip-Seq_TH2_Human | 1.20943949 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20528554 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15905604 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13857201 |
| 72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12714596 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12383624 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11579917 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11259875 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10830974 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10814505 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10711846 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10138366 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08048007 |
| 81 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.07827123 |
| 82 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07208597 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06256956 |
| 84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06233059 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06127423 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05769934 |
| 87 | * MYB_26560356_Chip-Seq_TH1_Human | 1.05497447 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04994011 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04398818 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03740477 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03719271 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03516456 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03312016 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02874477 |
| 95 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02844710 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02297388 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01098819 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00333214 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99754446 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99081485 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98042938 |
| 102 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97809345 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97188718 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97188718 |
| 105 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96220468 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95901602 |
| 107 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95494877 |
| 108 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94778222 |
| 109 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94207211 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94127616 |
| 111 | MYC_22102868_ChIP-Seq_BL_Human | 0.93792012 |
| 112 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93147773 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90969168 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90589190 |
| 115 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90510756 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89492544 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 0.89410532 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89291556 |
| 119 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88761346 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88416536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.66923700 |
| 2 | MP0003436_decreased_susceptibility_to | 3.41494928 |
| 3 | MP0003724_increased_susceptibility_to | 3.27379189 |
| 4 | MP0009840_abnormal_foam_cell | 3.20850237 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.89510844 |
| 6 | MP0002419_abnormal_innate_immunity | 2.64892453 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.63222756 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.57158498 |
| 9 | MP0009785_altered_susceptibility_to | 2.55937304 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.24866041 |
| 11 | MP0006082_CNS_inflammation | 2.21227540 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.18497091 |
| 13 | MP0005387_immune_system_phenotype | 2.18053385 |
| 14 | MP0001790_abnormal_immune_system | 2.18053385 |
| 15 | * MP0005025_abnormal_response_to | 2.15084787 |
| 16 | * MP0002148_abnormal_hypersensitivity_rea | 2.07745450 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.06080713 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.04048501 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.02867855 |
| 20 | MP0009278_abnormal_bone_marrow | 1.95646845 |
| 21 | MP0004947_skin_inflammation | 1.93703454 |
| 22 | MP0005360_urolithiasis | 1.92212275 |
| 23 | MP0000343_altered_response_to | 1.89984759 |
| 24 | * MP0002452_abnormal_antigen_presenting | 1.85444267 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.85140008 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.81751335 |
| 27 | MP0009764_decreased_sensitivity_to | 1.80157452 |
| 28 | MP0003075_altered_response_to | 1.80119394 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.75432062 |
| 30 | MP0001800_abnormal_humoral_immune | 1.72321524 |
| 31 | * MP0002723_abnormal_immune_serum | 1.69449399 |
| 32 | MP0000685_abnormal_immune_system | 1.61350850 |
| 33 | * MP0008469_abnormal_protein_level | 1.58874836 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.57321995 |
| 35 | MP0002405_respiratory_system_inflammati | 1.55128711 |
| 36 | MP0008004_abnormal_stomach_pH | 1.52917907 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.51536724 |
| 38 | * MP0001819_abnormal_immune_cell | 1.49541897 |
| 39 | * MP0002420_abnormal_adaptive_immunity | 1.48791459 |
| 40 | MP0005365_abnormal_bile_salt | 1.47285338 |
| 41 | MP0008260_abnormal_autophagy | 1.46652189 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.46639985 |
| 43 | MP0001853_heart_inflammation | 1.45361864 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.44835861 |
| 45 | * MP0003448_altered_tumor_morphology | 1.42358150 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.36755241 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.36733087 |
| 48 | MP0003828_pulmonary_edema | 1.34734902 |
| 49 | MP0001851_eye_inflammation | 1.33924214 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.33456331 |
| 51 | MP0005451_abnormal_body_composition | 1.31916424 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.28904549 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.28904549 |
| 54 | * MP0002998_abnormal_bone_remodeling | 1.28722194 |
| 55 | MP0000858_altered_metastatic_potential | 1.27316824 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.26545593 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.26228949 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23233988 |
| 59 | MP0005671_abnormal_response_to | 1.21107781 |
| 60 | * MP0003453_abnormal_keratinocyte_physiol | 1.20391592 |
| 61 | MP0002933_joint_inflammation | 1.20012014 |
| 62 | MP0005310_abnormal_salivary_gland | 1.19520368 |
| 63 | * MP0000609_abnormal_liver_physiology | 1.19410096 |
| 64 | MP0005166_decreased_susceptibility_to | 1.18991033 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.18980758 |
| 66 | MP0005023_abnormal_wound_healing | 1.16133006 |
| 67 | MP0003195_calcinosis | 1.13618483 |
| 68 | MP0003011_delayed_dark_adaptation | 1.12984498 |
| 69 | MP0003091_abnormal_cell_migration | 1.11540158 |
| 70 | MP0005164_abnormal_response_to | 1.10435761 |
| 71 | * MP0005076_abnormal_cell_differentiation | 1.09713086 |
| 72 | * MP0004510_myositis | 1.09666422 |
| 73 | MP0005083_abnormal_biliary_tract | 1.08825835 |
| 74 | * MP0005390_skeleton_phenotype | 1.08738642 |
| 75 | MP0009763_increased_sensitivity_to | 1.08674266 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.07011296 |
| 77 | MP0006054_spinal_hemorrhage | 1.04846557 |
| 78 | MP0002254_reproductive_system_inflammat | 1.04700459 |
| 79 | MP0003186_abnormal_redox_activity | 1.04666126 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.04359257 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.04207940 |
| 82 | MP0005275_abnormal_skin_tensile | 1.00736733 |
| 83 | MP0002060_abnormal_skin_morphology | 1.00567676 |
| 84 | MP0003252_abnormal_bile_duct | 1.00517466 |
| 85 | MP0000604_amyloidosis | 0.99606091 |
| 86 | MP0004883_abnormal_blood_vessel | 0.99245304 |
| 87 | * MP0000716_abnormal_immune_system | 0.98278891 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.97645542 |
| 89 | MP0002166_altered_tumor_susceptibility | 0.97518408 |
| 90 | MP0003329_amyloid_beta_deposits | 0.96487369 |
| 91 | MP0005670_abnormal_white_adipose | 0.94189587 |
| 92 | MP0004858_abnormal_nervous_system | 0.93330616 |
| 93 | MP0001542_abnormal_bone_strength | 0.92261565 |
| 94 | MP0000249_abnormal_blood_vessel | 0.92243013 |
| 95 | MP0003279_aneurysm | 0.92221490 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.91245882 |
| 97 | MP0002006_tumorigenesis | 0.89779856 |
| 98 | * MP0002118_abnormal_lipid_homeostasis | 0.87574941 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.87481716 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.85154991 |
| 101 | MP0003690_abnormal_glial_cell | 0.84616873 |
| 102 | * MP0000689_abnormal_spleen_morphology | 0.83472819 |
| 103 | MP0001849_ear_inflammation | 0.82712962 |
| 104 | MP0002796_impaired_skin_barrier | 0.82664411 |
| 105 | MP0005165_increased_susceptibility_to | 0.81642482 |
| 106 | MP0001873_stomach_inflammation | 0.81075477 |
| 107 | * MP0002722_abnormal_immune_system | 0.80944536 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.80916669 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.80422316 |
| 110 | MP0004130_abnormal_muscle_cell | 0.80236857 |
| 111 | MP0000598_abnormal_liver_morphology | 0.79693117 |
| 112 | * MP0003795_abnormal_bone_structure | 0.79527854 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.78934938 |
| 114 | * MP0002429_abnormal_blood_cell | 0.78777844 |
| 115 | MP0009115_abnormal_fat_cell | 0.78604057 |
| 116 | MP0001958_emphysema | 0.78587221 |
| 117 | * MP0002398_abnormal_bone_marrow | 0.78514163 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.77756767 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76666784 |
| 120 | MP0001663_abnormal_digestive_system | 0.74914513 |
| 121 | MP0002132_abnormal_respiratory_system | 0.74439156 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.74096674 |
| 123 | MP0004808_abnormal_hematopoietic_stem | 0.72875938 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.72295257 |
| 125 | MP0008874_decreased_physiological_sensi | 0.71416932 |
| 126 | MP0004233_abnormal_muscle_weight | 0.66842367 |
| 127 | MP0000920_abnormal_myelination | 0.66505209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.26679271 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.18163478 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.46851946 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.12287997 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.52297110 |
| 6 | Joint hemorrhage (HP:0005261) | 4.20337602 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.02495842 |
| 8 | Myocardial infarction (HP:0001658) | 3.84052331 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.53261502 |
| 10 | Complement deficiency (HP:0004431) | 3.39862456 |
| 11 | Orchitis (HP:0100796) | 3.39678702 |
| 12 | Myositis (HP:0100614) | 3.39201802 |
| 13 | Gingivitis (HP:0000230) | 3.38186638 |
| 14 | Abnormality of complement system (HP:0005339) | 3.35940341 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.35624656 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34286982 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.33560556 |
| 18 | Recurrent skin infections (HP:0001581) | 3.29374670 |
| 19 | Glomerulonephritis (HP:0000099) | 3.28628839 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.21726642 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.21041965 |
| 22 | Xanthomatosis (HP:0000991) | 3.15290513 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04658697 |
| 24 | Obstructive lung disease (HP:0006536) | 3.04658697 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.03766294 |
| 26 | Axonal loss (HP:0003447) | 2.99810996 |
| 27 | Stomatitis (HP:0010280) | 2.99739454 |
| 28 | Amyloidosis (HP:0011034) | 2.99100923 |
| 29 | Peritonitis (HP:0002586) | 2.98568206 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.95954661 |
| 31 | Urticaria (HP:0001025) | 2.89516260 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.85596858 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76112892 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.76112892 |
| 35 | Disinhibition (HP:0000734) | 2.76090174 |
| 36 | Neurofibrillary tangles (HP:0002185) | 2.74070130 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73104135 |
| 38 | Menorrhagia (HP:0000132) | 2.72953664 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.69293572 |
| 40 | Nephritis (HP:0000123) | 2.68037166 |
| 41 | Gingival bleeding (HP:0000225) | 2.67027988 |
| 42 | Cellulitis (HP:0100658) | 2.65548481 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.64770374 |
| 44 | Pustule (HP:0200039) | 2.62346430 |
| 45 | Periodontitis (HP:0000704) | 2.60359664 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.59946944 |
| 47 | Nuclear cataract (HP:0100018) | 2.56764374 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56483120 |
| 49 | Optic neuritis (HP:0100653) | 2.53529649 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.53529649 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52443268 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52443268 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52443268 |
| 54 | Thick nail (HP:0001805) | 2.51518139 |
| 55 | Prolonged partial thromboplastin time (HP:0003645) | 2.49647905 |
| 56 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.48006568 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.48006568 |
| 58 | Tetraparesis (HP:0002273) | 2.32207439 |
| 59 | Increased IgE level (HP:0003212) | 2.31770685 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.30450704 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29241256 |
| 62 | Epistaxis (HP:0000421) | 2.27254937 |
| 63 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26435530 |
| 64 | Mutism (HP:0002300) | 2.26291125 |
| 65 | Hematochezia (HP:0002573) | 2.25607378 |
| 66 | Vasculitis (HP:0002633) | 2.22394360 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.20112478 |
| 68 | Arterial thrombosis (HP:0004420) | 2.19895675 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.18456349 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.17351765 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16494561 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16494561 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16494561 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16174075 |
| 75 | Petechiae (HP:0000967) | 2.15201594 |
| 76 | Premature rupture of membranes (HP:0001788) | 2.14794365 |
| 77 | Increased serum ferritin (HP:0003281) | 2.14663586 |
| 78 | Malnutrition (HP:0004395) | 2.13376503 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.12979940 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.09294628 |
| 81 | Osteomyelitis (HP:0002754) | 2.06836086 |
| 82 | Pulmonary embolism (HP:0002204) | 2.04727023 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.04650999 |
| 84 | Hyperlipoproteinemia (HP:0010980) | 2.03340410 |
| 85 | Intrahepatic cholestasis (HP:0001406) | 2.02814087 |
| 86 | Bone pain (HP:0002653) | 2.01569362 |
| 87 | Esophageal varix (HP:0002040) | 2.00938764 |
| 88 | Episodic fever (HP:0001954) | 2.00704997 |
| 89 | Mitral stenosis (HP:0001718) | 2.00391375 |
| 90 | Gangrene (HP:0100758) | 1.99907381 |
| 91 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97091070 |
| 92 | Anorexia (HP:0002039) | 1.96884786 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 1.96856137 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95753089 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95753089 |
| 96 | Hydroxyprolinuria (HP:0003080) | 1.95541466 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 1.95541466 |
| 98 | Pathologic fracture (HP:0002756) | 1.95528033 |
| 99 | Hypertriglyceridemia (HP:0002155) | 1.95356980 |
| 100 | Meningitis (HP:0001287) | 1.93978520 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 1.93030349 |
| 102 | Purpura (HP:0000979) | 1.92935380 |
| 103 | Chronic otitis media (HP:0000389) | 1.91671942 |
| 104 | Loss of speech (HP:0002371) | 1.91204365 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 1.89988783 |
| 106 | Hemoptysis (HP:0002105) | 1.89913284 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 1.89145338 |
| 108 | Epidermoid cyst (HP:0200040) | 1.86925645 |
| 109 | Hepatosplenomegaly (HP:0001433) | 1.85802136 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85443573 |
| 111 | Pulmonary infiltrates (HP:0002113) | 1.85128901 |
| 112 | Increased connective tissue (HP:0009025) | 1.85002498 |
| 113 | Polycythemia (HP:0001901) | 1.83876358 |
| 114 | Asymmetric septal hypertrophy (HP:0001670) | 1.83819843 |
| 115 | Diminished motivation (HP:0000745) | 1.83422148 |
| 116 | Leukocytosis (HP:0001974) | 1.82893279 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.82445542 |
| 118 | Thoracic kyphosis (HP:0002942) | 1.82402561 |
| 119 | Achilles tendon contracture (HP:0001771) | 1.81065840 |
| 120 | Apathy (HP:0000741) | 1.80529281 |
| 121 | Acne (HP:0001061) | 1.80473374 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80397644 |
| 123 | Nasal polyposis (HP:0100582) | 1.79950773 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79665947 |
| 125 | Recurrent viral infections (HP:0004429) | 1.78506944 |
| 126 | Thin bony cortex (HP:0002753) | 1.78496541 |
| 127 | Polyneuropathy (HP:0001271) | 1.74991091 |
| 128 | Spondylolisthesis (HP:0003302) | 1.74582336 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 1.71996107 |
| 130 | Prolonged bleeding time (HP:0003010) | 1.71798653 |
| 131 | Encephalitis (HP:0002383) | 1.70783895 |
| 132 | Premature loss of primary teeth (HP:0006323) | 1.70264824 |
| 133 | Abnormality of the endocardium (HP:0004306) | 1.69000813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.21628026 |
| 2 | MAP4K1 | 3.18317857 |
| 3 | TBK1 | 3.13467028 |
| 4 | PRPF4B | 2.97519042 |
| 5 | MAP3K14 | 2.91344844 |
| 6 | BLK | 2.87255524 |
| 7 | IRAK3 | 2.72966051 |
| 8 | EPHB1 | 2.49301230 |
| 9 | TGFBR2 | 2.42743982 |
| 10 | TYK2 | 2.34839990 |
| 11 | TRIB3 | 2.34288301 |
| 12 | TAOK1 | 2.25141167 |
| 13 | IRAK4 | 2.18907330 |
| 14 | IKBKE | 2.13236736 |
| 15 | CSK | 2.07285083 |
| 16 | RIPK4 | 2.01345649 |
| 17 | PIM2 | 1.86718697 |
| 18 | DDR2 | 1.81019219 |
| 19 | FGFR4 | 1.77361946 |
| 20 | IKBKB | 1.75237116 |
| 21 | PKN2 | 1.74639846 |
| 22 | KIT | 1.63442178 |
| 23 | PBK | 1.60687801 |
| 24 | EPHA3 | 1.57741063 |
| 25 | STK10 | 1.56975940 |
| 26 | FGR | 1.54044300 |
| 27 | JAK1 | 1.52646076 |
| 28 | BMX | 1.51516651 |
| 29 | TAOK3 | 1.48853880 |
| 30 | MAP2K3 | 1.41531511 |
| 31 | CDC42BPA | 1.37960970 |
| 32 | MAP3K3 | 1.37625465 |
| 33 | JAK3 | 1.34838464 |
| 34 | NME2 | 1.30742538 |
| 35 | PIM1 | 1.23179345 |
| 36 | IRAK2 | 1.22249163 |
| 37 | ZAP70 | 1.22048468 |
| 38 | MAP3K11 | 1.21407605 |
| 39 | TTN | 1.20994919 |
| 40 | HCK | 1.20516968 |
| 41 | FES | 1.18641122 |
| 42 | JAK2 | 1.18088965 |
| 43 | PTK6 | 1.16699950 |
| 44 | MST1R | 1.16537411 |
| 45 | SIK1 | 1.12868989 |
| 46 | RIPK1 | 1.11856977 |
| 47 | NEK9 | 1.07727561 |
| 48 | RPS6KA4 | 1.05282329 |
| 49 | BTK | 1.02369427 |
| 50 | CSF1R | 1.01390987 |
| 51 | CHUK | 0.99992181 |
| 52 | MOS | 0.99681723 |
| 53 | MATK | 0.99369674 |
| 54 | CAMK1D | 0.97159462 |
| 55 | TXK | 0.93008613 |
| 56 | CDK6 | 0.92836529 |
| 57 | SMG1 | 0.92669592 |
| 58 | MAP2K2 | 0.89940520 |
| 59 | LRRK2 | 0.86215090 |
| 60 | CLK1 | 0.85741656 |
| 61 | ICK | 0.85510771 |
| 62 | MST4 | 0.84515661 |
| 63 | PAK4 | 0.84387198 |
| 64 | TNK2 | 0.83424297 |
| 65 | MAP3K10 | 0.82978022 |
| 66 | TRPM7 | 0.82020834 |
| 67 | PDPK1 | 0.81875293 |
| 68 | MAPK15 | 0.81844827 |
| 69 | PRKD2 | 0.80913957 |
| 70 | ARAF | 0.80206523 |
| 71 | TESK1 | 0.79908455 |
| 72 | MAP3K1 | 0.77490138 |
| 73 | MARK2 | 0.77214163 |
| 74 | FGFR3 | 0.76849134 |
| 75 | TEC | 0.76763040 |
| 76 | SIK3 | 0.76158298 |
| 77 | MARK3 | 0.75002563 |
| 78 | PDGFRA | 0.73575659 |
| 79 | MAP3K13 | 0.73567251 |
| 80 | BMPR2 | 0.73409828 |
| 81 | LCK | 0.72860805 |
| 82 | LYN | 0.72492389 |
| 83 | TESK2 | 0.71561914 |
| 84 | MAP3K6 | 0.71233857 |
| 85 | GRK6 | 0.70949300 |
| 86 | IRAK1 | 0.67437841 |
| 87 | SYK | 0.66271669 |
| 88 | MAPK12 | 0.64594972 |
| 89 | BCKDK | 0.64445611 |
| 90 | DAPK3 | 0.63884983 |
| 91 | LATS2 | 0.62660480 |
| 92 | EGFR | 0.59614021 |
| 93 | KDR | 0.59419511 |
| 94 | FLT3 | 0.58989872 |
| 95 | GSK3A | 0.58141004 |
| 96 | MAPK7 | 0.57668271 |
| 97 | MAPKAPK2 | 0.57423421 |
| 98 | NLK | 0.56775591 |
| 99 | PDK1 | 0.56250561 |
| 100 | GRK7 | 0.56228899 |
| 101 | RPS6KA2 | 0.53718803 |
| 102 | MAP2K6 | 0.53369771 |
| 103 | EIF2AK2 | 0.52255249 |
| 104 | MAP3K5 | 0.51258175 |
| 105 | PDGFRB | 0.50810799 |
| 106 | * ABL1 | 0.48673153 |
| 107 | PRKCD | 0.47733674 |
| 108 | DYRK1B | 0.45735004 |
| 109 | DAPK2 | 0.44687104 |
| 110 | PIK3CG | 0.44529509 |
| 111 | DMPK | 0.43521742 |
| 112 | EPHA2 | 0.43203851 |
| 113 | PRKG2 | 0.40900383 |
| 114 | ERBB4 | 0.40099108 |
| 115 | * ABL2 | 0.39400434 |
| 116 | KSR2 | 0.36994885 |
| 117 | MAPK11 | 0.36816314 |
| 118 | CDK9 | 0.35595016 |
| 119 | ITK | 0.35186104 |
| 120 | PTK2 | 0.34969191 |
| 121 | HIPK2 | 0.34617061 |
| 122 | DYRK3 | 0.33873269 |
| 123 | * RPS6KL1 | 0.33147678 |
| 124 | * RPS6KC1 | 0.33147678 |
| 125 | MAP3K8 | 0.33030449 |
| 126 | TAOK2 | 0.32590438 |
| 127 | ALK | 0.30455572 |
| 128 | * RPS6KA6 | 0.30106655 |
| 129 | CAMK1G | 0.29952864 |
| 130 | * MAPK4 | 0.29741744 |
| 131 | PRKAA2 | 0.29637560 |
| 132 | MTOR | 0.26699980 |
| 133 | FYN | 0.26549024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.18564574 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01352792 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75896473 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.36066085 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.33449796 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32589432 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12237927 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.11186677 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.06433896 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.83466064 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82044328 |
| 12 | * Tuberculosis_Homo sapiens_hsa05152 | 1.78304795 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75451392 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70313404 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70265810 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65045849 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64726261 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60583746 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50030554 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47862230 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46278931 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45876544 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.43571467 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40114615 |
| 25 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.39637015 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36051281 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34443730 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.31965102 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.30264593 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29793209 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29480541 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27774277 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.19230220 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.15562494 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12248376 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11814955 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10901625 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.10362716 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09263382 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.07371301 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05122512 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04635026 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03261947 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01641515 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01615329 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01327602 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00480371 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99680129 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99584649 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98245409 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97906100 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95655012 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94870956 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93974921 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93356187 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.92351095 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87199073 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86554185 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.85625798 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.85164469 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84869587 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.83301796 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82023800 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81918105 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81260643 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78636972 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76815016 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76483994 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75249971 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75139581 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73598006 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72542493 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72031863 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71035961 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70865305 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.70412686 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70327111 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.70216584 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68773793 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.68266669 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67926467 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67820693 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67063987 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63084555 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62525855 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62203729 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61144750 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60679305 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.59054586 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58694464 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57845434 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57270884 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57260889 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56207696 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55866829 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55745921 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.55672153 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53822967 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53522602 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.53436156 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53101077 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52882545 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51973648 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51904531 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51192694 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50751616 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50374872 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47590048 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46858145 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46380928 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46176279 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46081185 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.45861004 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.44553770 |
| 115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44278106 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43546133 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43197367 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42978217 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42895902 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42643599 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42431103 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41178484 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39928012 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39489038 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38718583 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37837686 |
| 127 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37319264 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37227183 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37001597 |
| 130 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34391812 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32507580 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31636752 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30517389 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28278758 |

